中国老年学杂志
中國老年學雜誌
중국노년학잡지
Chinese Journal of Gerontology
2015年
21期
6128-6129
,共2页
吕嘉%邢峰%丘瑾%冯砯锦%张博%成佳景
呂嘉%邢峰%丘瑾%馮砯錦%張博%成佳景
려가%형봉%구근%풍빙금%장박%성가경
子宫内膜癌%雌激素受体%孕激素受体%p53
子宮內膜癌%雌激素受體%孕激素受體%p53
자궁내막암%자격소수체%잉격소수체%p53
Endometrial carcinoma%ER%PR%p53
目的:探讨雌激素受体( ER)、孕激素受体( PR)和p53在老年子宫内膜癌患者中的表达及意义。方法采用免疫组织化学Envision法检测21例老年子宫内膜癌(老年组)与40例非老年子宫内膜癌(非老年组)患者中ER、PR和p53蛋白的表达。结果 ER、PR、p53阳性率在老年组和非老年组中分别为71.4%、76.2%、81%和77.5%、90%、57.5%,PR表达在两组间有显著性差异( P=0.036)。 p53阳性表达与年龄呈正相关(r=0.279,P=0.029)。结论 PR和p53在不同年龄子宫内膜癌中的表达差异与肿瘤生物学行为及预后有一定关系。老年患者的 PR表达较非老年患者显著降低,而这会影响两组人群孕激素的治疗效果。
目的:探討雌激素受體( ER)、孕激素受體( PR)和p53在老年子宮內膜癌患者中的錶達及意義。方法採用免疫組織化學Envision法檢測21例老年子宮內膜癌(老年組)與40例非老年子宮內膜癌(非老年組)患者中ER、PR和p53蛋白的錶達。結果 ER、PR、p53暘性率在老年組和非老年組中分彆為71.4%、76.2%、81%和77.5%、90%、57.5%,PR錶達在兩組間有顯著性差異( P=0.036)。 p53暘性錶達與年齡呈正相關(r=0.279,P=0.029)。結論 PR和p53在不同年齡子宮內膜癌中的錶達差異與腫瘤生物學行為及預後有一定關繫。老年患者的 PR錶達較非老年患者顯著降低,而這會影響兩組人群孕激素的治療效果。
목적:탐토자격소수체( ER)、잉격소수체( PR)화p53재노년자궁내막암환자중적표체급의의。방법채용면역조직화학Envision법검측21례노년자궁내막암(노년조)여40례비노년자궁내막암(비노년조)환자중ER、PR화p53단백적표체。결과 ER、PR、p53양성솔재노년조화비노년조중분별위71.4%、76.2%、81%화77.5%、90%、57.5%,PR표체재량조간유현저성차이( P=0.036)。 p53양성표체여년령정정상관(r=0.279,P=0.029)。결론 PR화p53재불동년령자궁내막암중적표체차이여종류생물학행위급예후유일정관계。노년환자적 PR표체교비노년환자현저강저,이저회영향량조인군잉격소적치료효과。
Objective To investigate the expressions of estrogen receptor ( ER) ,progesterone receptor ( PR) and p53 in senile pa-tients with endometrial carcinoma and their clinical importance.Methods The expressions of ER,PR and p53 in 21 senile patients ( senile group) and 40 nonsenile patients ( nonsenile group) with endometrial carcinoma were tested by immunohistochemistry Envision method.Re-sults The positive rates of ER,PR,p53 in senile group and nonsenile group were 71.4%,76.2%,81% and 85%,90%,57.5%,respec-tively.The expression of PR between the two groups was significantly different ( P=0.036) .The positive expression of p53 was increased with age advanced (r=0.279,P=0.029).Conclusions The expression discrepancy of PR and p53 in different ages of endometrial carcinoma might be related to tumor biological behavior and prognosis.The expression of PR is significantly decreased in senile group compared with that in nonsenile group,and this would affect the treatment outcome of progesterone in the two groups.